MYO7A Gene Deafness Autosomal Dominant Type 11 Genetic Test sale cost 4400 AED
GJB2 Gene Deafness with Keratopachydermia and Constrictions of Fingers and Toes Genetic Test sale cost 4400 AED GJB2 Gene Deafness with Keratopachydermia and Constrictions of Fingers and Toes Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
GIPC3 Gene Deafness Autosomal Recessive Type 15 Genetic Test sale cost 4400 AED GIPC3 Gene Deafness Autosomal Recessive Type 15 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

MYO7A Gene Deafness Autosomal Dominant Type 11 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The MYO7A Gene Deafness Autosomal Dominant Type 11 Genetic Test is a specialized diagnostic assessment offered by DNA Labs UAE, aimed at identifying mutations in the MYO7A gene, which are linked to a form of autosomal dominant non-syndromic hearing loss. This condition, known as Autosomal Dominant Deafness Type 11, is characterized by varying degrees of hearing impairment that can affect individuals differently, even within the same family. The test is crucial for families with a history of hearing loss, as it can provide valuable insights into the genetic underpinnings of their condition, enabling informed decisions about management and treatment options. Conducted in a state-of-the-art laboratory setting, the test involves analyzing the patient’s DNA sample to look for specific genetic alterations associated with this type of hearing loss. The cost of the MYO7A Gene Deafness Autosomal Dominant Type 11 Genetic Test at DNA Labs UAE is 4400 AED, reflecting the advanced technology and expertise required to accurately identify the presence of MYO7A gene mutations.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

MYO7A Gene Deafness autosomal dominant type 11 Genetic Test

Are you concerned about your hearing loss? DNA Labs UAE offers the MYO7A Gene Deafness autosomal dominant type 11 Genetic Test to help diagnose and understand this condition.

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test type: Ear Nose Throat Disorders
  • Doctor: ENT Doctor
  • Test Department: Genetics

Pre Test Information

Before undergoing the MYO7A Gene Deafness autosomal dominant type 11 Genetic Test, it is important to provide the clinical history of the patient. This includes information about any family members affected by SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test. A Genetic Counselling session will be conducted to draw a pedigree chart of family members affected with SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test gene SLC52A3.

Test Details

The MYO7A gene is responsible for producing a protein called myosin VIIA, which plays a crucial role in the function of hair cells in the inner ear. Mutations in the MYO7A gene can lead to a condition known as deafness, autosomal dominant type 11. This form of hearing loss is inherited in an autosomal dominant pattern, meaning it can be passed down from one generation to the next.

NGS (Next-Generation Sequencing) genetic testing is a cutting-edge method that allows for the analysis of multiple genes simultaneously. In the case of MYO7A gene deafness, NGS genetic testing can be used to identify mutations or variants in the MYO7A gene that may be responsible for the condition. The test can be performed on a blood or saliva sample, which is then sent to our certified laboratory for DNA extraction and sequencing.

NGS genetic testing provides valuable information for individuals and families affected by MYO7A gene deafness. It aids in diagnosis, prognosis, and genetic counseling. Additionally, NGS testing can also be used for carrier testing in individuals who have a family history of MYO7A gene deafness but do not exhibit any symptoms themselves.

It is crucial to note that NGS genetic testing is a complex process that should only be performed by trained professionals in a certified laboratory. We strongly recommend genetic counseling before and after testing to ensure a comprehensive understanding of the implications of the results and to make informed decisions about your healthcare.

Don’t let hearing loss go undiagnosed. Contact DNA Labs UAE today to schedule your MYO7A Gene Deafness autosomal dominant type 11 Genetic Test and take control of your hearing health.

Test Name MYO7A Gene Deafness autosomal dominant type 11 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Ear Nose Throat Disorders
Doctor ENT Doctor
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test gene SLC52A3
Test Details

The MYO7A gene is responsible for producing a protein called myosin VIIA, which is involved in the function of hair cells in the inner ear. Mutations in the MYO7A gene can lead to a condition called deafness, autosomal dominant type 11.

Deafness, autosomal dominant type 11 is an inherited form of hearing loss that is passed down from one generation to the next in an autosomal dominant pattern. This means that an affected individual has a 50% chance of passing the condition on to their children.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses high-throughput sequencing technologies to analyze multiple genes simultaneously. In the case of MYO7A gene deafness, NGS genetic testing can be used to identify mutations or variants in the MYO7A gene that may be responsible for the condition.

NGS genetic testing for MYO7A gene deafness can be performed on a blood or saliva sample. The sample is sent to a laboratory where the DNA is extracted and sequenced. The sequencing data is then analyzed to identify any mutations or variants in the MYO7A gene.

NGS genetic testing can provide valuable information for individuals and families affected by MYO7A gene deafness. It can help with diagnosis, prognosis, and genetic counseling. Additionally, NGS testing can also be used for carrier testing in individuals who have a family history of MYO7A gene deafness but do not show any symptoms themselves.

It is important to note that NGS genetic testing is a complex process and should be performed by trained professionals in a certified laboratory. Genetic counseling is recommended before and after testing to help individuals understand the implications of the results and make informed decisions about their healthcare.

SKU: TEST-2673 Category:

Related products